August 18, 2025

Cytokinetics, Incorporated (CYTK) Stock Analysis: Biotechnology Pioneer with an 83% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the biotechnology sector, promising significant growth potential for investors willing to navigate the complexities of pharmaceutical innovation. With a market capitalization of $4.63..

Rhythm Pharmaceuticals, Inc. (RYTM): Investor Outlook on a Biotech with 15% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention as it positions itself at the forefront of the biotechnology sector. Specializing in treatments for rare neuroendocrine diseases, the company is..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring 39.65% Potential Upside in Healthcare Innovation

Waystar Holding Corp. (NASDAQ: WAY), a dynamic player in the healthcare information services sector, is drawing significant attention from investors due to its promising growth trajectory and an attractive 39.65%..

Bausch + Lomb (BLCO) Stock Analysis: Navigating Eye Health with a 4% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO) is a key player in the healthcare sector, operating within the medical instruments and supplies industry. With a substantial market capitalization of $5.15 billion,..

BrightSpring Health Services (BTSG) Stock Analysis: Exploring the 27.93% Potential Upside

BrightSpring Health Services, Inc. (BTSG), a prominent player in the healthcare sector, specifically within the health information services industry, has been drawing increasing attention from investors due to its impressive..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Growth Potential in Biotech with a 21.56% Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is making waves in the biotechnology sector, particularly for investors keen on high-growth opportunities. With a market cap of $8.24 billion, this healthcare player is..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: A Biotech Pioneer with an 8.94% Upside Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands out in the biotechnology sector with its focus on developing innovative RNA-targeted therapeutics and gene therapies for rare diseases such as Duchenne muscular dystrophy...

Option Care Health, Inc. (OPCH) Stock Analysis: Unveiling a 36.93% Potential Upside

In the dynamic realm of healthcare, Option Care Health, Inc. (NASDAQ: OPCH) stands out as a significant player within the medical care facilities industry. With a market capitalization of $4.6..

Corcept Therapeutics Inc. (CORT) Stock Analysis: Robust Growth Potential with 87% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out as an intriguing prospect in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $7.56 billion, Corcept Therapeutics is..

Chemed Corp (CHE) Stock Analysis: Uncovering a 27% Potential Upside in the Healthcare Sector

As investors navigate the intricate landscape of healthcare stocks, Chemed Corp (NYSE: CHE) emerges as a compelling candidate with a noteworthy potential upside. With a market capitalization of $6.49 billion,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unlocking a 21% Potential Upside with Strong Buy Ratings

Investors with a keen eye on the healthcare sector might find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing prospect, particularly given its strong market position in the Medical Instruments..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A Promising 26% Upside Potential Awaits Investors

Neurocrine Biosciences, Inc. (NBIX), a pivotal player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, is capturing investor attention with a substantial market cap of..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 19.69% Potential Upside in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) is a compelling entity within the biotechnology industry, offering significant opportunities for investors with its innovative product lines and strategic partnerships. Headquartered in Minneapolis, Minnesota, Bio-Techne..

Teleflex Incorporated (TFX) Investor Outlook: Exploring a 16.10% Potential Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, is capturing investor attention with a potential upside of 16.10%, according to recent analyst ratings. Specializing in the design..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Biotech Innovator with Over 63% Potential Upside

Investors with an eye on the healthcare sector might find Soleno Therapeutics, Inc. (SLNO) an intriguing opportunity. The company, headquartered in Redwood City, California, operates within the biotechnology industry and..

Integer Holdings Corporation (ITGR) Stock Analysis: Strong Buy Ratings Signal a Potential 31.92% Upside

For investors scouting opportunities in the healthcare sector, Integer Holdings Corporation (NYSE: ITGR) emerges as a compelling candidate. This Plano, Texas-based medical device manufacturer operates globally, delivering a wide array..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Exploring a 36.75% Potential Upside in Genetic Medicine

Krystal Biotech, Inc. (NASDAQ: KRYS), a pioneering commercial-stage biotechnology firm, is capturing the attention of investors with its promising advancements in genetic medicine and a significant potential upside of 36.75%...

Repligen Corporation (RGEN) Investor Outlook: Analyzing the 44.54% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, is making waves with its innovative bioprocessing technologies. As the company continues to expand its footprint across North America,..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a Potential 13.67% Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector, is garnering attention from investors due to its robust market position and promising growth potential. Headquartered in Barcelona, Spain,..

Hologic, Inc. (HOLX) Stock Analysis: Evaluating the 8.24% Upside Potential in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a major player in the healthcare sector, stands out for its commitment to women’s health through innovative diagnostics, medical imaging systems, and surgical products. With a..

Search

Funds

August 18, 2025

Search

Funds

August 18, 2025

FTSE 100

Funds